knowledge -WSS

knowledge

author：leisure time 2025-09-28 03:50:52 - browse：13

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Abortion pill case raises question: who can sue the FDA?

focus

WSS

Patient advocates debate FDA's accelerated approval process

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

House panel to mark up pandemic

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Abortion pill case raises question: who can sue the FDA?

entertainment

knowledge

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Neutralizing antibodies against HIV shows promise in children

Novavax promises a turnaround & Lilly roils the obesity market

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Duchenne breakthrough therapy leaves behind pioneering families

The PBM ad wars are taking over Washington, D.C.

Cancer drug shortages should be causing more outrage

Primary care physicians play key roles in Alzheimer's management

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: mifepristone case, GLP

Wikipedia

FDA approves Leqembi, a milestone in Alzheimer’s treatment

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Food as medicine: Medically tailored meals may get standardized

Vertex Pharmaceuticals may move headquarters in Boston

Vertex Pharmaceuticals may move headquarters in Boston

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

focus

focus

hotspot

explore